Canon India Pvt. Ltd expanded its PIXMA printer series with the launch of two new models - PIXMA TS3170 and PIXMA E3170. The new PIXMA printers are equipped with a segmentLCD display with intuitive icons that guide the user through all operations; from wireless setup to making multiple copies using different document sizes. The operation panel of the printers feature one-touch switching to direct wireless connection and back to standard network infrastructure mode. Both the printers feature a fingerprint and scratch resistant glossy grid pattern. TS3170 is best suited for occasional printing and is compatible with affordable cartridge - Canon PG-745s and CL-746S. PIXMA E3170 is best suited for everyday printing and is compatible with ink efficient cartridges PG-47 and Cl-57s which provides low cost printing of up to 400 monochrome documents and 180 color documents. PIXMA TS3170 and PIXMA E3170 are available at the cost of INR 4,995 and INR 5,995 respectively.
Japan's leading printer and photocopier maker Konica Minolta Inc. announced at the company will be acquiring Ambry Genetic Corp. - a US diagnostic company, in a deal valued at up to USD 1 billion. This is one of the largest deals for Konica Minolta and the company will jointly carry out the acquisition with the funds provided by Innovation Network Corp of Japan. Konica Minolta, which has a market value of around $4 billion, will account for 60 percent of the investment and the Innovation Network Corp of Japan (INCJ) will provide for the remaining 40 percent. Both the companies intend to enter into the precision medicine segment which is expected to have a great potential for the treatment of cancer. KMI has its own diagnostic technique, utilising a High Sensitive Tissue Testing (HSTT) technology, while Ambry excels in genetic tests for breast, colon and cancers, heart and respiratory diseases, etc. Further, the company will combine its HSTT technology and Ambry's genetic diagnostic technology to offer high-standard cancer diagnostic services and aid the development of new reagents which will help produce new medicines. Talking about the acquisition, Shoei Yamana - Chief Executive Officer of Konica Minolta Inc., said, “Together with Ambry, we will have the most comprehensive set of diagnostic technologies for mapping an individual's genetic and biochemical makeup." The companies expect to complete the necessary procedure for the deal by the end of October, 2017 and post which, Ambry will become a subsidiary of KMI while Ambry's business will be continued in the US.
Konica Minolta and Screen Graphic Solutions (Screen GA) have strengthened their collaboration in the commercial digital printing area. The companies plan to promote hybrid workflows and increase user-friendliness in offset printing and digital printing. Plans also include further enhancement of efficiency, extending business opportunities, and delivering new value in the commercial printing industry. The seamless hybrid workflows will be achieved by improving data exchange between Screen GA's Equios and the Accurio portfolio of Konica Minolta. The companies have improved data exchange in the Job Definition Format between the Equios universal workflow systems and the Accurio inkjet and toner digital presses. The improved data : exchange allows users to directly carry out digital printing from the Equios, achieving seamless operation that features colour management and finishing. The solution increases commercial printing efficiency in a production; environment and provides new business opportunities by taking full advantage of ondemand printing. Screen GA business development division head and corporate officer Toru Kawada said the company has continuously improved the Equios universal workflow systems that combine CTP workflow systems with cutting-edge inkjet printing technologies.